CVS Capital Surpluse vs Deferred Long Term Liab Analysis
CVS Stock | USD 56.26 0.26 0.46% |
CVS Health financial indicator trend analysis is way more than just evaluating CVS Health Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CVS Health Corp is a good investment. Please check the relationship between CVS Health Capital Surpluse and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Capital Surpluse vs Deferred Long Term Liab
Capital Surpluse vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CVS Health Corp Capital Surpluse account and Deferred Long Term Liab. At this time, the significance of the direction appears to have weak relationship.
The correlation between CVS Health's Capital Surpluse and Deferred Long Term Liab is 0.32. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of CVS Health Corp, assuming nothing else is changed. The correlation between historical values of CVS Health's Capital Surpluse and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of CVS Health Corp are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Capital Surpluse i.e., CVS Health's Capital Surpluse and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | 0.32 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Capital Surpluse
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from CVS Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CVS Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, CVS Health's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.21 in 2024, whereas Tax Provision is likely to drop slightly above 2 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Operating Income | 13.2B | 16.3B | 13.7B | 14.4B | Other Operating Expenses | 277.1B | 306.4B | 601.0B | 631.0B |
CVS Health fundamental ratios Correlations
Click cells to compare fundamentals
CVS Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CVS Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Short Long Term Debt Total | 89.0B | 85.0B | 76.0B | 70.7B | 79.4B | 83.4B | |
Other Current Liab | 4.8B | 5.8B | 5.6B | 47.6B | 2.5B | 2.3B | |
Total Current Liabilities | 53.3B | 62.0B | 67.8B | 69.7B | 79.2B | 83.1B | |
Total Stockholder Equity | 63.9B | 69.4B | 75.1B | 71.0B | 76.5B | 80.3B | |
Property Plant And Equipment Net | 32.9B | 33.3B | 32.0B | 30.7B | 30.4B | 32.0B | |
Net Debt | 83.3B | 77.2B | 66.6B | 57.8B | 71.2B | 74.7B | |
Retained Earnings | 45.1B | 49.6B | 54.9B | 56.1B | 61.6B | 64.7B | |
Cash | 5.7B | 7.9B | 9.4B | 12.9B | 8.2B | 8.6B | |
Non Current Assets Total | 172.1B | 174.3B | 173.0B | 162.6B | 181.9B | 191.0B | |
Non Currrent Assets Other | 4.6B | 4.6B | 4.7B | 4.0B | 3.6B | 3.8B | |
Cash And Short Term Investments | 8.1B | 10.9B | 12.5B | 15.7B | 11.5B | 12.0B | |
Net Receivables | 19.6B | 21.7B | 24.4B | 27.3B | 35.2B | 37.0B | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 984.2M | |
Liabilities And Stockholders Equity | 222.4B | 230.7B | 233.0B | 228.3B | 249.7B | 262.2B | |
Non Current Liabilities Total | 105.0B | 99.0B | 89.8B | 87.2B | 93.9B | 98.6B | |
Inventory | 17.5B | 18.5B | 17.8B | 19.1B | 18.0B | 18.9B | |
Other Current Assets | 5.1B | 5.3B | 5.3B | 2.7B | 3.2B | 3.3B | |
Other Stockholder Equity | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (33.8B) | (32.1B) | |
Total Liab | 158.3B | 161.0B | 157.6B | 157.0B | 173.1B | 181.7B | |
Property Plant And Equipment Gross | 32.9B | 33.3B | 12.9B | 12.9B | 51.1B | 53.7B | |
Total Current Assets | 50.3B | 56.4B | 60.0B | 65.7B | 67.9B | 71.3B | |
Accumulated Other Comprehensive Income | 1.0B | 1.4B | 965M | (1.5B) | (297M) | (311.9M) | |
Short Term Debt | 5.4B | 7.1B | 5.9B | 3.5B | 4.7B | 4.9B | |
Intangible Assets | 33.1B | 31.1B | 29.0B | 24.8B | 29.2B | 30.7B | |
Accounts Payable | 10.5B | 11.1B | 12.5B | 14.8B | 14.9B | 15.6B | |
Common Stock | 46.0B | 46.5B | 47.4B | 48.2B | 49.0B | 51.4B | |
Good Will | 79.7B | 79.6B | 79.1B | 78.2B | 91.3B | 95.8B | |
Common Stock Total Equity | 46.0B | 46.5B | 47.4B | 48.2B | 55.4B | 58.2B | |
Other Liab | 21.4B | 21.0B | 19.7B | 19.9B | 22.9B | 24.1B | |
Other Assets | 9.1B | 51.0B | 9.8B | 7.6B | 8.7B | 4.8B | |
Long Term Debt | 64.7B | 59.2B | 52.0B | 50.5B | 58.6B | 61.6B | |
Treasury Stock | (28.2B) | (28.2B) | (28.2B) | (31.9B) | (28.7B) | (27.2B) | |
Property Plant Equipment | 32.9B | 12.6B | 12.9B | 12.9B | 14.8B | 9.5B | |
Current Deferred Revenue | 32.6B | 38.0B | 43.8B | 3.9B | 57.1B | 60.0B | |
Short Term Investments | 2.4B | 3B | 3.1B | 2.8B | 3.3B | 3.4B | |
Net Tangible Assets | (49.0B) | (41.3B) | (33.1B) | 71.0B | 63.9B | 67.1B | |
Noncontrolling Interest In Consolidated Entity | 318M | 306M | 312M | 300M | 345M | 362.3M | |
Retained Earnings Total Equity | 45.1B | 49.6B | 54.9B | 56.1B | 64.6B | 39.9B | |
Long Term Debt Total | 64.7B | 59.2B | 52.0B | 50.5B | 58.0B | 34.0B |
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving against CVS Stock
0.92 | TMDX | TransMedics Group | PairCorr |
0.73 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
0.67 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
0.6 | SGHT | Sight Sciences | PairCorr |
0.6 | MLAB | Mesa Laboratories Financial Report 23rd of May 2024 | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.47) | Dividend Share 2.48 | Earnings Share 5.7 | Revenue Per Share 281.151 | Quarterly Revenue Growth 0.036 |
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.